From the 20 samples, for which we conducted plasma analyses, 12 had a ctDNA AF above 3%, 7 of them had an FGFR1 amplification, whereas the other 5 cases had no copy number alteration of the FGFR1 region. The gene discussed is FGFR1; the disease is atrial fibrillation.